Catherine Sebban

Centre Léon Bérard — France

Medicine · Health Sciences

45h-index8.8kcitations147works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(77), Chronic Lymphocytic Leukemia Research(35), Acute Lymphoblastic Leukemia research(25), Acute Myeloid Leukemia Research(19), Viral-associated cancers and disorders(19)

Publications147 total

A Multistate Survival Analysis for Patients with Follicular Lymphoma (FL) Using 13 First-Line Randomized Trials from FL Analysis of Surrogate Hypothesis (FLASH) Group
Blood·2019
HIGH TOTAL METABOLIC TUMOR VOLUME AT BASELINE ALLOWS TO DISCRIMINATE FOR SURVIVAL PATIENTS IN RESPONSE AFTER R‐CHOP: AN ANCILLARY ANALYSIS OF THE REMARC STUDY
Hematological Oncology·2019· 3 cited
Long‐term fatigue in survivors of non‐Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross‐sectional study
Cancer·2019· 24 citedOpen Access
Impact of Total Metabolic Tumor Volume at Baseline in the Remarc Study
Blood·2018
REMARC STUDY: CORRELATION OF LYMPHOMA PD AND DEATH AND HEALTH‐RELATED QOL WITH MAINTENANCE LENALIDOMIDE VS PLACEBO IN ELDERLY DLBCL PATIENT RESPONDERS TO R‐CHOP
Hematological Oncology·2017Open Access
LOW NK CELL COUNT AT DIAGNOSIS IS ASSOCIATED WITH SHORTER PFS IN ELDERLY PATIENTS WITH DLBCL TREATED WITH RCHOP AND RANDOMIZED FOR LENALIDOMIDE MAINTENANCE: a LYSA STUDY
Hematological Oncology·2017Open Access
CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES FOR YOUNG PATIENTS WITH FIRST‐LINE FOLLICULAR LYMPHOMA: A POOLED ANALYSIS OF 4249 PATIENTS FROM THE FLASH DATABASE.
Hematological Oncology·2017· 1 citedOpen Access
Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy
Journal of Clinical Oncology·2017· 183 cited
ABVD or BEACOPPbaseline along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors : Results of the European Organisation for Research and Treatment of Cancer (EORTC)–Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial
2017
[Conduct of epidemiologic studies in French cancer survivors: Methods, difficulties encountered and solutions provided. Lessons learned from the SIMONAL study on long-term toxicities after non-Hodgkin lymphoma treatment].
HAL (Le Centre pour la Communication Scientifique Directe)·2017
Impact of the Use of Polymerase Chain Reaction for the Diagnosis and Management of Pneumocystis Jirovecii Pneumoniae in a Retrospective Cohort of Patients with Lymphoid Malignancies
Blood·2016· 1 cited
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma
American Journal of Hematology·2016· 220 citedOpen Access
Monotherapy with pixantrone in histologically confirmed relapsed or refractory aggressive B‐cell non‐Hodgkin lymphoma: post‐hoc analyses from a phase <scp>III</scp> trial
British Journal of Haematology·2016· 28 citedOpen Access
Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group.
HAL (Le Centre pour la Communication Scientifique Directe)·2016
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network
Kölner Universitäts PublikationsServer (Universität zu Köln)·2016
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.
HAL (Le Centre pour la Communication Scientifique Directe)·2016
Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group
Haematologica·2015· 49 citedOpen Access
Combination of Rituximab with Chemotherapy Improved Outcome of Newly Diagnosed Primary CNS Lymphoma: A Retrospective Study of 209 Unselected Patients Referred to a Single Institution
Blood·2015· 1 cited
Granulomatoses apparues après une hémopathie : étude de 13 cas
La Revue de Médecine Interne·2015
Etoposide pharmacokinetics impact the outcomes of lymphoma patients treated with BEAM regimen and ASCT: a multicenter study of the LYmphoma Study Association (LYSA).
HAL (Le Centre pour la Communication Scientifique Directe)·2015· 1 cited
page 1 of 8Next →

Frequent Co-authors

Bertrand Coiffier(14), Gilles Salles(12), Éric Lepage(10), Pierre Biron(9), Pauline Brice(9), Jean‐Yves Blay(8), D Fière(8), Franck Morschhauser(7), Corinne Haïoun(7), Hervé Tilly(6), André Bosly(6), Christian Gisselbrecht(6), Philippe Moreau(6), Michel Attal(6), Christophe Fermé(5), P Lederlin(5), Hervé Avet‐Loiseau(5), Thierry Façon(5), Dominique Bordessoule(5), Olivier Casasnovas(5)